Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort

被引:6
作者
Lahat, Adi [1 ]
Fidder, Herma H. [2 ]
Ben-Horin, Shomron [3 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Sheba Med Ctr, Dept Gastroenterol, IL-52621 Tel Aviv, Israel
[2] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[3] Sackler Sch Med, Sheba Med Ctr, Dept Gastroenterol, Tel Aviv, Israel
关键词
acute diverticulitis; clinical score; diverticular disease; symptomatic uncomplicated diverticular disease; QUALITY-OF-LIFE; HEALTH SURVEY SF-36; COMPLICATED DIVERTICULITIS; DOUBLE-BLIND; MESALAZINE; COLON; MANAGEMENT; TRIAL; INDEX; RECURRENCE;
D O I
10.1177/1756284820913210
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Following an attack of acute diverticulitis (AD), many patients continue to suffer from a complex of symptoms, titled 'symptomatic uncomplicated diverticular disease (SUDD)'. To date, there is no validated clinical score for standardized assessment of patients with SUDD, thereby hampering the interpretation of observational studies and the conductance of clinical trials. We aimed to develop a validated SUDD clinical score. Methods: Data from previous prospective study of patients after AD was used to devise the score's first version. Validation was first performed using a focus group of patients after AD SUDD who underwent a structured cognitive personal interview. Thereafter, the diverticular clinical score (DICS) was applied for a second validation cohort. DICS scores of validation cohort were compared with physicians' global assessment for disease severity and inflammatory markers. Results: In DICS second validation using 48 patients prospectively recruited after AD SUDD, a correlation matrix demonstrated strong correlation between total questionnaire's score and the presence of elevated inflammatory markers (rho = 0.84). Mean score in patients with elevated inflammatory markers compared with those without inflammation was 17.8 versus 6.2, respectively, p < 0.001. Cronbach's alpha for measuring internal consistency was 0.91. DICS discriminated accurately between patients with/without active disease, as gauged by the physicians global assessment (area under the curve receiver operating characteristic = 0.989). Conclusions: Patients suffering from post-AD SUDD exhibit a wide range of symptoms. The newly developed DICS accurately and reproducibly quantitates SUDD-related symptom severity. The DICS may prove useful for monitoring SUDD in clinical practice and in research settings, as well as facilitating patient stratification and therapeutic decisions.
引用
收藏
页数:11
相关论文
共 60 条
[41]   Long-term Risk of Acute Diverticulitis Among Patients With Incidental Diverticulosis Found During Colonoscopy [J].
Shahedi, Kamyar ;
Fuller, Garth ;
Bolus, Roger ;
Cohen, Erica ;
Vu, Michelle ;
Shah, Rena ;
Agarwal, Nikhil ;
Kaneshiro, Marc ;
Atia, Mary ;
Sheen, Victoria ;
Kurzbard, Nicole ;
van Oijen, Martijn G. H. ;
Yen, Linnette ;
Hodgkins, Paul ;
Erder, M. Haim ;
Spiegel, Brennan .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (12) :1609-1613
[42]   Patterns of pain in diverticular disease and the influence of acute diverticulitis [J].
Simpson, J ;
Neal, KR ;
Scholefield, JH ;
Spiller, RC .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (09) :1005-1010
[43]   Origin of symptoms in diverticular disease [J].
Simpson, J ;
Scholefield, JH ;
Spiller, RC .
BRITISH JOURNAL OF SURGERY, 2003, 90 (08) :899-908
[44]   MECHANISTIC RANDOMISED CONTROL TRIAL OF MESALAZINE IN SYMPTOMATIC DIVERTICULAR DISEASE [J].
Smith, J. ;
Humes, D. ;
Garsed, K. ;
Lam, C. ;
Zaitoun, A. ;
Bennett, A. ;
Scholefield, J. ;
Spiller, R. .
GUT, 2012, 61 :A51-A52
[45]   Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL [J].
Spiegel, Brennan M. R. ;
Reid, Mark W. ;
Bolus, Roger ;
Whitman, Cynthia B. ;
Talley, Jennifer ;
Dea, Stanley ;
Shahedi, Kamyar ;
Karsan, Hetal ;
Teal, Chassidy ;
Melmed, Gil Y. ;
Cohen, Erica ;
Fuller, Garth ;
Yen, Linnette ;
Hodgkins, Paul ;
Erder, M. Haim .
QUALITY OF LIFE RESEARCH, 2015, 24 (01) :163-179
[46]   A Randomized Controlled Study of Mesalamine After Acute Diverticulitis: Results of the DIVA Trial [J].
Stollman, Neil ;
Magowan, Simon ;
Shanahan, Fergus ;
Quigley, Eamonn M. M. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (07) :621-629
[47]   Epidemiology, Pathophysiology, and Treatment of Diverticulitis [J].
Strate, Lisa L. ;
Morris, Arden M. .
GASTROENTEROLOGY, 2019, 156 (05) :1282-+
[48]  
Trepsi E, 1999, Minerva Gastroenterol Dietol, V45, P245
[49]   Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon -: A prospective, randomized, open-label study [J].
Tursi, A ;
Brandimarte, G ;
Giorgetti, GM ;
Elisei, W .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (04) :312-316
[50]   Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study [J].
Tursi, A. ;
Brandimarte, G. ;
Elisei, W. ;
Picchio, M. ;
Forti, G. ;
Pianese, G. ;
Rodino, S. ;
D'Amico, T. ;
Sacca, N. ;
Portincasa, P. ;
Capezzuto, E. ;
Lattanzio, R. ;
Spadaccini, A. ;
Fiorella, S. ;
Polimeni, F. ;
Polimeni, N. ;
Stoppino, V. ;
Stoppino, G. ;
Giorgetti, G. M. ;
Aiello, F. ;
Danese, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (07) :741-751